Whether your egg was of the plastic, chocolate, or old fashioned white-and-yolk variety we hope you had a good weekend. The IN VIVO Blog is still recovering from a long week of conferencing in New York and we should have a few more thoughts to share from PSO later this week. Meanwhile here are a few things you may have missed over the weekend. That sound you might have heard was the utter destruction of our NCAA tourney bracket ...
- The Times examines the market for hip replacement in the US, where British firms Smith & Nephew and Corin are competing with new, longer-lasting joints.
- Fan of Bad Science? Get an earful from Ben Goldacre tonight on Radio 4.
- Lowe and behold: In the Pipeline's review of Pfizer's attempts at prying open the process of scientific publishing. So far it's journals, 2, Pfizer, 0, with one contest remaining.
- David Hamilton at VentureBeat has the goods on ImmunoNewco, the stealthy 5AM Ventures investment that has acquired the Danish biotech Borean Pharma. (For more on Borean, check out our 2005 profile.)